COOP CMC, Formulation Development in Massachusetts

Foghorn Therapeutics, a prominent clinical-stage biotechnology company, is seeking a highly motivated and skilled candidate to join their team as a 2024 COOP CMC Formulation Development. The successful candidate will have the opportunity to work in a dynamic and fast-paced environment as part of a team that is revolutionizing the field of chromatin regulation. Foghorn Therapeutics aims to develop a new class of medicines that modulate the chromatin regulatory system, thus orchestrating the genes our cells express, including when, where, and in what order. With over 10 programs in various stages of development, the company is aggressively pursuing treatments for a wide range of cancers and other diseases. A commitment to making a real difference in the lives of fellow human beings underpins the company's mission.

Responsibilities

• Co-Op period: through December, 2024 or January, 2025 starting summer 2024 (starting date is flexible)
• Learn and...